Subtitle
Protons vs Photons for Brain and Skull Base Tumors.
Subtitle
Protons vs Photons for Brain and Skull Base Tumors.
Proto therapy Time
April 2018
Executive summary
A systematic review summarizes the literature regarding the role of proton therapy compared to photon therapy in the treatment of adult brain and skull base tumors, including chordoma/chondrosarcoma, glioma, meningioma, pituitary tumor, acoustic neuroma, and craniopharyngioma.
Top cancer treatments
Related contents
Proton Therapy Publication

November 2024
Short-course hypofractionated proton beam therapy, incorporating 18F-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnosed glioblastoma: a single-arm phase 2 trial.
en
Proton Therapy Publication

September 2024
Proton therapy for adult-type diffuse glioma: A systematic review.
en
Proton Therapy Publication

October 2024
Brain volume loss after cranial irradiation: a controlled comparison study between photon vs proton radiotherapy for WHO grade 2-3 gliomas.
en
Proton Therapy Publication

October 2024
Patient reported fatigue after proton therapy for malignant brain tumours - Is there a relation between radiation dose and brain structures?
en
Proton Therapy Publication

September 2024
Analysis of safety and efficacy of proton radiotherapy for optic nerve sheath meningioma.
en
Proton Therapy Publication

May 2024
Optimizing radiotherapy strategies for skull base chordoma: a comprehensive meta-analysis and systematic review of treatment modalities and outcomes.
en
Proton Therapy Publication

May 2024
Proton versus photon adjuvant radiotherapy: a multicenter comparative evaluation of recurrence following spinal chordoma resection.
en
Proton Therapy Publication

June 2024
Possible association of dose rate and the development of late visual toxicity for patients with intracranial tumours treated with pencil beam scanned proton therapy.
en
Proton Therapy Publication

August 2024
Proton therapy for intracranial meningioma: a single-institution retrospective analysis of efficacy, survival and toxicity outcomes.
en